PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
Synapse
⌘+K
Synapse
May 1, 2026Open Access

Inflammatory Cytokines as Potential Biomarkers for Monitoring Therapeutic Response in Bladder Cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

ANAliaa Mohammed NamaMHMohsin Kazem Hassan

Discussion

Loading...

Member takes

Overview

Randomized trial evaluates cytokines for monitoring treatment response in bladder cancer, suggesting new biomarker potential.

Key Points

  • The study aims to assess the role of inflammatory cytokines as non-invasive biomarkers for monitoring therapeutic response in bladder cancer.
  • Enrolled 80 patients with bladder cancer and 30 healthy controls.
  • Classified patients into pre-treatment and post-treatment groups.
  • Measured serum levels of IL-2, IL-6, and TNF-α, and analyzed them based on treatment status and duration.
  • IL-2 and IL-6 levels significantly increased in the post-treatment group compared to controls.
  • TNF-α levels were elevated in bladder cancer patients, regardless of treatment status.
  • IL-6 levels increased progressively and significantly across all groups, correlating positively with longer therapy duration.

Cite This Study

Nama et al. (2026) studied this question.

synapsesocial.com/papers/69f444d3967e944ac55679dchttps://doi.org/10.5281/zenodo.19877764
View Full Paper
Ask AI
Bookmark
Share